- Home
- IGC vs WKSP Comparison
IGC vs WKSP Comparison
Compare IGC & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- WKSP
- Stock Information
- Founded
- IGC 2005
- WKSP 2003
- Country
- IGC United States
- WKSP United States
- Employees
- IGC N/A
- WKSP N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- IGC Health Care
- WKSP Consumer Discretionary
- Exchange
- IGC Nasdaq
- WKSP Nasdaq
- Market Cap
- IGC 29.4M
- WKSP 27.5M
- IPO Year
- IGC N/A
- WKSP N/A
- Fundamental
- Price
- IGC $0.37
- WKSP $0.92
- Analyst Decision
- IGC Strong Buy
- WKSP Strong Buy
- Analyst Count
- IGC 2
- WKSP 1
- Target Price
- IGC $3.75
- WKSP $2.00
- AVG Volume (30 Days)
- IGC 469.7K
- WKSP 2.9M
- Earning Date
- IGC 02-12-2025
- WKSP 11-13-2024
- Dividend Yield
- IGC N/A
- WKSP N/A
- EPS Growth
- IGC N/A
- WKSP N/A
- EPS
- IGC N/A
- WKSP N/A
- Revenue
- IGC $1,183,000.00
- WKSP $6,395,908.00
- Revenue This Year
- IGC N/A
- WKSP $366.78
- Revenue Next Year
- IGC $13.57
- WKSP $311.43
- P/E Ratio
- IGC N/A
- WKSP N/A
- Revenue Growth
- IGC N/A
- WKSP 776.97
- 52 Week Low
- IGC $0.27
- WKSP $0.36
- 52 Week High
- IGC $0.91
- WKSP $1.57
- Technical
- Relative Strength Index (RSI)
- IGC 49.16
- WKSP 59.55
- Support Level
- IGC $0.33
- WKSP $0.78
- Resistance Level
- IGC $0.38
- WKSP $0.91
- Average True Range (ATR)
- IGC 0.03
- WKSP 0.12
- MACD
- IGC -0.00
- WKSP -0.00
- Stochastic Oscillator
- IGC 44.44
- WKSP 42.42
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers.